about
Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach.Evolution of a mini-scale biphasic dissolution model: Impact of model parameters on partitioning of dissolved API and modelling of in vivo-relevant kinetics.Model-based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation.Modeling energy intake and body weight effects of a long-acting amylin analogue.Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic ProcessesMechanistic study on hydrodynamics in the mini-scale biphasic dissolution model and its influence on in vitro dissolution and partitioning
P50
Q35768436-5F01041B-128F-409A-8EBB-D18CB203F8A1Q36618141-C77F7026-2A8E-4C49-A7F0-1D3163016F0EQ39686109-7841FE95-8FC2-4DB6-B239-44BFBCABC9D6Q39794883-E905AD5E-EFCB-4D8E-905D-E89D60DEB3AAQ47175680-C90F8626-1D09-41C5-A6B3-9D1849A732FDQ90298512-15F420D5-CBF0-446B-8C71-07A0BB7E405BQ91340635-F0002423-0D81-4AE3-AD09-13BDD846ADED
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jens Markus Borghardt
@ast
Jens Markus Borghardt
@en
Jens Markus Borghardt
@es
Jens Markus Borghardt
@nl
type
label
Jens Markus Borghardt
@ast
Jens Markus Borghardt
@en
Jens Markus Borghardt
@es
Jens Markus Borghardt
@nl
prefLabel
Jens Markus Borghardt
@ast
Jens Markus Borghardt
@en
Jens Markus Borghardt
@es
Jens Markus Borghardt
@nl
P106
P1153
56586207200
P31
P496
0000-0001-7000-9308